176 related articles for article (PubMed ID: 11902491)
1. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.
Kitami A; Suzuki T; Kamio Y; Suzuki S
Jpn J Clin Oncol; 2001 Dec; 31(12):601-4. PubMed ID: 11902491
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
[TBL] [Abstract][Full Text] [Related]
3. [Complete resection for giant thymic carcinoma after simultaneous combination chemotherapy].
Ueki T; Ueshima Y; Kurioka H; Enoki Y; Hosokawa Y
Kyobu Geka; 2005 Apr; 58(4):320-3. PubMed ID: 15828254
[TBL] [Abstract][Full Text] [Related]
4. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
5. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of eight thymic carcinomas].
Tanaka A; Osawa H; Yamauchi A; Asahina H; Kikuchi H; Ogura S; Yamamoto K; Ikeda H; Koshiba R
Kyobu Geka; 2002 Oct; 55(11):971-5. PubMed ID: 12391695
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of thymoma].
Monden Y; Uyama T; Kimura S; Takahashi K
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2019-24. PubMed ID: 2221924
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of malignant thymoma. Case report and review of the literature.
Hu E; Levine J
Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N
Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
[TBL] [Abstract][Full Text] [Related]
12. [ADOC regimen for unresectable advanced thymic cancer].
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Takashi S; Tsukadaira A; Masubuchi T; Yamamoto H; Kaneki T; Yamaguchi S; Hachiya T; Hayasaka M; Fujimoto K; Kubo K
Nihon Kokyuki Gakkai Zasshi; 1999 Dec; 37(12):970-3. PubMed ID: 10707536
[TBL] [Abstract][Full Text] [Related]
13. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Berruti A; Tampellini M; Gorzegno G; Dogliotti L
Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
[No Abstract] [Full Text] [Related]
14. [Successful treatment of intrapericardial administration of carboplatin following systemic chemotherapy in a case of advanced thymic cancer with cardiac tamponade].
Okada M; Koizumi T; Yasuo M; Tsushima K; Urushihata K; Yamaguchi S; Hanaoka M; Fujimoto K; Kubo K
Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):968-72. PubMed ID: 17233396
[TBL] [Abstract][Full Text] [Related]
15. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
[TBL] [Abstract][Full Text] [Related]
16. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.
Loehrer PJ; Bonomi P; Goldman S; Reddy S; Faber LP; Jensik R; Dainauskas JR
Chest; 1985 Mar; 87(3):377-80. PubMed ID: 3971764
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
19. [Thymic anaplastic carcinoma successfully controlled by combination chemotherapy].
Nakanishi F; Sakamoto K; Shijubo N; Shiratori M; Honma S
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):613-7. PubMed ID: 9805913
[TBL] [Abstract][Full Text] [Related]
20. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
